Its ability to stabilize specific mRNAs like p21 (CDKN1A) highlights a sophisticated layer of gene regulation that integrates the NPC with the core components of cell cycle control and apoptosis, offering insights into novel cancer therapeutic strategies to prevent HCC progression [109]. This evidence concerns the gene CDKN1A and cancer.